Euromonitor International’s Senior Research Analyst Alex Esposito interviews Cindy Bryant, Chief Business Officer at Demetrix about the world of cannabinoids beyond THC and CBD. Cindy explains Demetrix’s unique approach to using fermentation to produce cannabinoids and how this differs from predominant production methods. Alex and Cindy also delve into the potential of new cannabinoids other than THC and CBD, ways they can help consumers and how we’re only just beginning to understand the promise of cannabinoids for use in health and wellness. Learn more about Demetrix at their website, and dive into their unique approach to producing cannabinoids their blog.
Nicotine and Cannabis
Explore thought-leadership and expert insights on the consumer behaviour, regulatory forces and cutting-edge innovation trends shaping the complex and rapidly developing nicotine and cannabis industries.
Find content by
Cannabinoids Beyond THC and CBD: An Interview with Cindy Bryant, Chief Business Officer at Demetrix
2/24/2021
Share:
Explore More
Shop Our Reports
The World Market for Fast-Moving Consumer Goods: Outlook and Opportunities
The global FMCG market is projected to grow by 4.6% in current value terms to reach USD6.6 trillion. Growth is largely price led and financial concerns are…
View ReportWhere Consumers Shop for Nicotine
As the nicotine industry continues its transformation so does the retail landscape for nicotine products globally. This report explores the latest developments…
View ReportWhat’s Happening in Nicotine and Cannabis - H1 2025
The nicotine and cannabis markets continue their evolution and are expected to reach a combined USD1.2 trillion in value by 2029. It becomes critical to…
View Report